|
85
|
239
|
7rs8A |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-16 |
|
88
|
249
|
7rs7A |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-30 |
|
91
|
247
|
7rs4A |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-8 |
|
88
|
252
|
7rs2A |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-23 |
|
88
|
240
|
7rrxA |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-19 |
|
91
|
242
|
7rs0A |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-18 |
|
85
|
241
|
7rrzA |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-30 |
|
87
|
242
|
7rs3A |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-29 |
|
90
|
243
|
7rs9A |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-25 |
|
88
|
244
|
7rryA |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-20 |
|
84
|
240
|
7rs8D |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-16 |
|
86
|
242
|
7rs1A |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-21 |
|
48
|
225
|
6cdyA |
Crystal structure of tead complexed with its inhibitor |
|
47
|
225
|
6uybA |
Crystal structure of tead2 bound to compound 1 |
|
185
|
552
|
6nuqA |
Stat3 core in complex with compound si109 |
|
183
|
552
|
6njsA |
Stat3 core in complex with compound sd36 |
|
98
|
268
|
6o67A |
Crystal structure of human ppargamma ligand binding domain in complex with mitoglitazone |
|
91
|
270
|
6o68A |
Crystal structure of human ppargamma ligand binding domain in complex with ciglitazone |
|
38
|
127
|
6mh1A |
Crystal structure of the first bromodomain of human brd4 in complex with hu-10, a 1,4,5-trisubstituted imidazole analogue |
|
0
|
4
|
5x54C |
Crystal structure of the keap1 kelch domain in complex with a tetrapeptide |
|
0
|
4
|
3pslC |
Fine-tuning the stimulation of mll1 methyltransferase activity by a histone h3 based peptide mimetic |
|
42
|
109
|
6moaA |
C-terminal bromodomain of human brd2 in complex with 4-(2-cyclopropyl-7-(6-methylquinolin-5-yl)-1h-benzo[d]imidazol-5-yl)-3,5-dimethylisoxazole inhibitor |
|
41
|
114
|
6mo7A |
N-terminal bromodomain of human brd2 with n-((4-(3-(n-cyclopentylsulfamoyl)-4-methylphenyl)-3-methylisoxazol-5-yl)methyl)acetamide inhibitor |
|
41
|
114
|
6mo9A |
N-terminal bromodomain of human brd2 in complex with n-cyclopentyl-7-(3,5-dimethylisoxazol-4-yl)quinoline-5-sulfonamide inhibitor |
|
42
|
114
|
6mo8A |
N-terminal bromodomain of human brd2 in complex with 4,4'-(quinoline-5,7-diyl)bis(3,5-dimethylisoxazole) inhibitor |
|
97
|
268
|
6md2A |
Crystal structure of human ppargamma ligand binding domain in complex with gw9662 and arachidonic acid |
|
98
|
268
|
6md4A |
Crystal structure of human ppargamma ligand binding domain in complex with rosiglitazone and oleic acid |
|
76
|
333
|
6e3sB |
Crystal structure of the heterodimeric hif-2 complex with antagonist pt2385 |
|
68
|
328
|
6e3tB |
Crystal structure of the heterodimeric hif-2 complex with antagonist t1001 |
|
57
|
361
|
6e3tA |
Crystal structure of the heterodimeric hif-2 complex with antagonist t1001 |
|
41
|
127
|
6dmjA |
A multiconformer ligand model of inhibitor 53w bound to creb binding protein bromodomain |
|
42
|
127
|
6dmlA |
A multiconformer ligand model of 3,5 dimethylisoxaxole bound to the bromodomain of human brd4 |
|
40
|
113
|
6dmkA |
A multiconformer ligand model of an isoxazolyl-benzimidazole ligand bound to the bromodomain of human crebbp |
|
93
|
270
|
6dhaA |
Crystal structure of human ppargamma ligand binding domain in complex with hydroxy pioglitazone (m-iv) |
|
72
|
367
|
6e3sA |
Crystal structure of the heterodimeric hif-2 complex with antagonist pt2385 |
|
83
|
242
|
6owcA |
Mutant estrogen receptor alpha (era) y537s covalently bound to h3b-6545. |
|
95
|
270
|
6dh9A |
Crystal structure of human ppargamma ligand binding domain in complex with msdc-0602 |
|
103
|
270
|
6dgrA |
Crystal structure of human ppargamma ligand binding domain in complex with cay10638 |
|
100
|
270
|
6dgqA |
Crystal structure of human ppargamma ligand binding domain in complex with cay10506 |
|
97
|
270
|
6dglA |
Crystal structure of human ppargamma ligand binding domain in complex with darglitazone |
|
94
|
268
|
6dgoA |
Crystal structure of human ppargamma ligand binding domain in complex with troglitazone |
|
38
|
110
|
5jwmA |
Bivalent bet bromodomain inhibition |
|
58
|
210
|
5ke3A |
Crystal structure of setdb1 tudor domain in complex with fragment mrt0181a |
|
51
|
180
|
5h1uA |
Complex structure of trim24 phd-bromodomain and inhibitor 2 |
|
48
|
127
|
5hclA |
Crystal structure of the first bromodomain of brd4 in complex with dma |
|
50
|
182
|
5h1tA |
Complex structure of trim24 phd-bromodomain and inhibitor 1 |
|
320
|
1340
|
4yfnC |
Escherichia coli rna polymerase in complex with squaramide compound 14 (n-[3,4-dioxo-2-(4-{[4-(trifluoromethyl)benzyl]amino}piperidin-1-yl)cyclobut-1-en-1-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide) |
|
309
|
1369
|
4yfkD |
Escherichia coli rna polymerase in complex with squaramide compound 8. |
|
40
|
229
|
4yfxA |
Escherichia coli rna polymerase in complex with myxopyronin b |
|
23
|
89
|
4yfnE |
Escherichia coli rna polymerase in complex with squaramide compound 14 (n-[3,4-dioxo-2-(4-{[4-(trifluoromethyl)benzyl]amino}piperidin-1-yl)cyclobut-1-en-1-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide) |
